Thomas Lodise
Disclosures: NO DISCLOSURE
Thomas Lodise, Pharm

 

Thomas Lodise, Pharm.D, Ph.D.

Thomas Lodise, Pharm.D., Ph.D., is Professor at Albany College of Pharmacy and Health Sciences, Albany, New York. He is also an infectious diseases clinical pharmacy specialist at the Stratton VA Medical Center, Albany, New York.  Integrating his dual interests in research and patient care, his overall research goal is to quantitatively enhance our current understanding of antimicrobial exposure-response relationships in patients with invasive bacterial infections. His research encompasses three interrelated domains: pharmacokinetics (PK)/pharmacodynamics (PD), epidemiology, and outcomes.  He has published over 140 peer-reviewed articles in numerous medical and pharmacy journals.  He is a scientific editor for Pharmacotherapy and is an editorial board member for Antimicrobial Agents and Chemotherapy and Diagnostic Microbiology and Infectious Diseases. He is a member of the vancomycin consensus guideline committee.  He is the current chair of the PK Special Emphasis Panel for the Antibacterial Resistance Leadership Group (ARLG) (https://arlg.org), an initiative funded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH).

1